EUVIMEDEUVIMED entdecken
Crossref

Injectable thermoresponsive hydrogel scaffold for enhanced delivery of next-generation induced neural stem cells for treatment of glioblastoma

Kayla M Maue, Nour Caroline Dau, Jasmine L King, Morrent Thang, Shawn D Hingtgen, Soumya Rahima Benhabbour

Drug Delivery and Translational Research · 2026-11 · 16 (11) · 4101-4116

DOI: 10.1007/s13346-026-02087-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 09.04.2026. Verfasst von Kayla M Maue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lampe Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill, Chapel Hill, N…. Hauptthemen laut MEDLINE: Neural Stem Cells, Glioblastoma, Brain Neoplasms, Hydrogels. Die Arbeit nennt 52 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) remains a highly aggressive brain tumor with poor prognosis despite surgical resection and standard chemoradiation. Induced neural stem cell (iNSC)-based therapies offer a promising strategy owing to their inherent tumor-homing ability and capacity to deliver therapeutics selectively to the tumor site; however, their poor retention within the tumor resection cavity limits clinical potential. Herein, we evaluated next-generation tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-secreting iNSCs (hiNeuroS) in combination with a biodegradable, thermo-responsive chitosan hydrogel for localized and sustained delivery of high densities of hiNeuroS. Direct comparisons with first-generation iNSCs (hiNSCs) demonstrated that hiNeuroS achieved faster and more extensive tumor cell kill across multiple tumor-to-therapeutic cell ratios in both U87 and patient-derived GBM8 models. Injectable chitosan scaffolds supported stem cell densities up to 2 × 10⁷ cells/mL, maintained > 90% viability, preserved scaffold microstructure, and maintained rapid gelation at physiological conditions. Gravimetric analysis revealed stable 30-day mass change profiles, with minimal net mass loss indicating preserved scaffold integrity. Moreover, encapsulated hiNeuroS retained their migratory capacity and robust TRAIL secretion, inducing significant tumor cell death in both GBM models. Collectively, these findings demonstrate that hiNeuroS maintain functional potency in GBM and are compatible with scaffold-based delivery. This work provides a foundation for future in vivo studies to assess scaffold-mediated retention, persistence, and therapeutic efficacy in an established GBM mouse model, supporting the development of an injectable hydrogel platform for next-generation cell-based therapies for treatment of GBM and other malignant tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neural Stem CellsGlioblastomaBrain NeoplasmsHydrogelsHumansAnimalsChitosanTNF-Related Apoptosis-Inducing LigandCell Line, TumorMiceTemperatureTissue ScaffoldsInjectionsCell Survival

Stichwörter der Autor:innen

ChitosanGlioblastomaInjectable hydrogelNeural stem cellTRAIL

Substanzen

ChitosanTNF-Related Apoptosis-Inducing LigandHydrogels

Autor:innen und Institutionen

  • Lampe Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Lampe Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. benhabs@email.unc.edu.
  • Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. benhabs@email.unc.edu.

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Maue, K. M., Dau, N. C., King, J. L., Thang, M., Hingtgen, S. D., & Benhabbour, S. R. (2026). Injectable thermoresponsive hydrogel scaffold for enhanced delivery of next-generation induced neural stem cells for treatment of glioblastoma. Drug Delivery and Translational Research, 16(11), 4101-4116. https://doi.org/10.1007/s13346-026-02087-9

Vancouver

Maue KM, Dau NC, King JL, Thang M, Hingtgen SD, Benhabbour SR. Injectable thermoresponsive hydrogel scaffold for enhanced delivery of next-generation induced neural stem cells for treatment of glioblastoma. Drug Delivery and Translational Research. 2026;16(11):4101-4116. doi:10.1007/s13346-026-02087-9

BibTeX
@article{Maue2026,
  author = {Maue, Kayla M and Dau, Nour Caroline and King, Jasmine L and Thang, Morrent and Hingtgen, Shawn D and Benhabbour, Soumya Rahima},
  title = {Injectable thermoresponsive hydrogel scaffold for enhanced delivery of next-generation induced neural stem cells for treatment of glioblastoma},
  journal = {Drug Delivery and Translational Research},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {4101--4116},
  doi = {10.1007/s13346-026-02087-9}
}
Kostenlos starten →